Picture of EQL Pharma AB logo

EQL — EQL Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapNeutral

Brief: Eql Pharma's Rights Issue Subscribed To Approximately 161.7 Percent

EQL Pharma AB  EQL.TE :
    * EQL PHARMA'S RIGHTS ISSUE SUBSCRIBED TO APPROXIMATELY
161.7
PERCENT
    * RIGHTS ISSUE RAISES PROCEEDS OF APPROXIMATELY MSEK 24.9
BEFORE
ISSUE COSTS OF APPROXIMATELY MSEK 1.7.

Source text for Eikon:  ID:nWkr9tb44x 
Further company coverage:  EQL.TE

Recent news on EQL Pharma AB

See all news